v3.26.3
Condensed Interim Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Cash flows from operating activities    
Net loss $ (11,748,757) $ (2,046,684)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization expense 12,888 5,477
Depreciation expense 10,408 5,127
Fixed asset, disposed 2,740 0
Gain on conversion of payables 0 (43,176)
Warrants issued for services 0 263,453
Warrants issued to related parties 0 149,374
Options issued for services 1,493,977 0
Shares issued for services 3,081,289 480,496
Loss on write-off of offering costs 73,169 0
Operating lease - right of use 9,841 0
Changes in operating assets and liabilities:    
Accounts payable and accrued liabilities 524,865 1,785
Accounts payable and accrued liabilities - related parties 45,374 0
Interest receivable (2,426) 0
Taxes receivable 3,037 (11,962)
Wages payable (76,000) 0
Prepaid expenses (3,524,559) (42,300)
Security deposit (18,475) 0
Lease liability (9,000) 0
Liability to be settle by shares 22,350 0
Net cash used in operating activities (10,099,279) (1,238,410)
Cash flow from investing activities    
Purchase of fixed assets (76,229) (18,668)
Change in convertible note receivables (2) 0
Loan receivable 0 (40,386)
Net cash used in investing activities (76,231) (59,054)
Cash flow from financing activities    
Receivable form issuance of private placement shares 2,000,000 0
Repayments on due to shareholders 0 (4,189)
Proceeds for shares issued under the warrant inducement program 2,720,561 0
Proceeds for warrants issued under the warrant inducement program 5,526 0
Proceeds received for performance warrants exercised 1,750 0
Proceeds from private placement, net of issuance costs 2,943,351 2,018,413
Repayments on insurance funding agreement (92,187) 0
Repayment of loan payable 0 (94,206)
Offering costs paid for future offering (30,992) (99,627)
Net cash provided by financing activities 7,548,009 1,820,391
Effect of exchange rate changes on cash 2,997 (4,415)
Increase in cash, cash equivalents and restricted cash (2,627,501) 522,927
Cash, cash equivalents and restricted cash at beginning of period 4,834,120 314,616
Cash, cash equivalents and restricted cash at end of period 2,209,616 833,128
Supplemental cash flow information    
Cash paid for interest 0 17,547
Cash paid for taxes 0 0
Non-cash investing and financing activities    
Shares issued for prepaid expenses 0 353,262
Warrants issued for services to be expensed 0 218,724
Investment 71,328 0
Prepaid insurance from funding agreement 469,785 0
New right of use addition 81,482 0
Shares issued for conversion of payables $ 0 $ 122,897